- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Ultrasound IDs patients at higher risk for stroke
Using transcranial Doppler ultrasound to detect asymptomatic cerebral emboli can identify patients who are at a higher risk of stroke and transient ischemic attack as well as those with a low absolute stroke risk, according to an international study.
Using transcranial Doppler ultrasound to detect asymptomatic cerebral emboli can identify patients who are at a higher risk of stroke and transient ischemic attack as well as those with a low absolute stroke risk, according to an international study.
The technique might also be useful in selecting patients with asymptomatic carotid stenosis who are likely to benefit from endarterectomy.
Embolic signs-short duration, high-energy signals-were present in 77 of 467 patients at baseline. The hazard ratio for the risk of ipsilateral stroke and transient ischemic attack from baseline to two years in patients with embolic signals compared with those without was 2.54. The hazard ratio for ipsilateral stroke alone was 5.57 (Lancet DOI:10.1016/S1474-4422(10)70120-4).
Absolute annual risk of ipsilateral stroke or a transient ischemic attack between baseline and two years was 7.13% in patients with embolic signals and 3.04% in those without. The absolute annual risk of ipsilateral stroke alone was 3.62% in patients with embolic signals and 0.7% in those without.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
FDA Clears AI-Powered Cardiovascular Ultrasound System from Siemens Healthineers
August 13th 2024Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.
